Literature DB >> 26418360

The Dutch Central Sensitization Inventory (CSI): Factor Analysis, Discriminative Power, and Test-Retest Reliability.

Jeroen Kregel1, Pieter J Vuijk, Filip Descheemaeker, Doeke Keizer, Robert van der Noord, Jo Nijs, Barbara Cagnie, Mira Meeus, Paul van Wilgen.   

Abstract

OBJECTIVES: A standardized assessment of central sensitization can be performed with the Central Sensitization Inventory (CSI), an English questionnaire consisting of 25 items relating to current health symptoms. The aim of this study was to translate the CSI into Dutch, to perform a factor analysis to reveal the underlying structure, examine its discriminative power, and test-retest reliability.
METHODS: The CSI was first translated into Dutch. A factor analysis was conducted on CSI data of a large group of chronic pain patients (n=368). The ability to discriminate between chronic pain patients (n=188) and pain-free controls (n=49) was determined and the test-retest reliability for chronic pain patients (n=36) and controls (n=45) with a time interval of 3 weeks was evaluated.
RESULTS: The exploratory factor analysis resulted in a 4-factor model based on 20 items, representing the domains "General disability and physical symptoms" (Cronbach α=0.80), "Higher central sensitivity"(Cronbach α=0.78), "Urological and dermatological symptoms"(Cronbach α=0.60), and "Emotional distress"(Cronbach α=0.80). Furthermore, a parsimonious second-order factor model was found, where the factor "General central sensitization" was underlying the 4 first-order factors. Chronic pain patients scored significantly worse on all 4 factors. The test-retest reliability was excellent values in both chronic pain patients (ICC=0.88) and controls (ICC=0.91). DISCUSSION: The original CSI was translated into Dutch and did not reveal any problems during data acquisition. The domains represented by the 4 factors may be useful in setting up specific patient profiles and treatment targets. To conclude, the Dutch CSI revealed 4 distinguishable domains, showed good internal consistency for the total score and 3 out of 4 domains, good discriminative power, and excellent test-retest reliability.

Entities:  

Mesh:

Year:  2016        PMID: 26418360     DOI: 10.1097/AJP.0000000000000306

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  23 in total

1.  A contemporary neuroscience approach compared to biomedically focused education combined with symptom-contingent exercise therapy in people with chronic whiplash associated disorders: a randomized controlled trial protocol.

Authors:  Iris Coppieters; Ward Willaert; Dorine Lenoir; Mira Meeus; Barbara Cagnie; Kelly Ickmans; Anneleen Malfliet; Lieven Danneels; Brenda De Petter; Jo Nijs
Journal:  Braz J Phys Ther       Date:  2020-10-10       Impact factor: 3.377

2.  Cross-cultural adaptation and validity of the Spanish central sensitization inventory.

Authors:  Antonio Ignacio Cuesta-Vargas; Cristina Roldan-Jimenez; Randy Neblett; Robert J Gatchel
Journal:  Springerplus       Date:  2016-10-21

Review 3.  Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists.

Authors:  Steven P Cohen; Anuj Bhatia; Asokumar Buvanendran; Eric S Schwenk; Ajay D Wasan; Robert W Hurley; Eugene R Viscusi; Samer Narouze; Fred N Davis; Elspeth C Ritchie; Timothy R Lubenow; William M Hooten
Journal:  Reg Anesth Pain Med       Date:  2018-07       Impact factor: 6.288

4.  Development and psychometric properties of short form of central sensitization inventory in participants with musculoskeletal pain: A cross-sectional study.

Authors:  Tomohiko Nishigami; Katsuyoshi Tanaka; Akira Mibu; Masahiro Manfuku; Satoko Yono; Akihito Tanabe
Journal:  PLoS One       Date:  2018-07-05       Impact factor: 3.240

5.  Cross-cultural adaptation and validation of the Korean version of the Central Sensitization Inventory in patients undergoing total knee arthroplasty for knee osteoarthritis.

Authors:  Man Soo Kim; In Jun Koh; Chul Kyu Kim; Keun Young Choi; Chang Yeon Kim; Yong In
Journal:  PLoS One       Date:  2020-12-01       Impact factor: 3.240

6.  Spinal postural variability relates to biopsychosocial variables in patients with cervicogenic headache.

Authors:  Sarah Mingels; Wim Dankaerts; Ludo van Etten; Liesbeth Bruckers; Marita Granitzer
Journal:  Sci Rep       Date:  2021-07-02       Impact factor: 4.379

7.  Validation of the Japanese version of the Central Sensitization Inventory in patients with musculoskeletal disorders.

Authors:  Katsuyoshi Tanaka; Tomohiko Nishigami; Akira Mibu; Masahiro Manfuku; Satoko Yono; Yoshikazu Shinohara; Akihito Tanabe; Rei Ono
Journal:  PLoS One       Date:  2017-12-07       Impact factor: 3.240

8.  The Central Sensitization Inventory validated and adapted for a Brazilian population: psychometric properties and its relationship with brain-derived neurotrophic factor.

Authors:  Wolnei Caumo; Luciana C Antunes; Jéssica Lorenzzi Elkfury; Evelyn G Herbstrith; Raquel Busanello Sipmann; Andressa Souza; Iraci Ls Torres; Vinicius Souza Dos Santos; Randy Neblett
Journal:  J Pain Res       Date:  2017-09-01       Impact factor: 3.133

9.  Central Sensitisation and functioning in patients with chronic low back pain: protocol for a cross-sectional and cohort study.

Authors:  Jone Ansuategui Echeita; Henrica R Schiphorst Preuper; Rienk Dekker; Ilse Stuive; Hans Timmerman; Andre P Wolff; Michiel F Reneman
Journal:  BMJ Open       Date:  2020-03-08       Impact factor: 2.692

10.  Central Sensitization in Chronic Low Back Pain: A Population-Based Study of a Japanese Mountain Village.

Authors:  Koji Akeda; Norihiko Takegami; Junichi Yamada; Tatsuhiko Fujiwara; Akinobu Nishimura; Akihiro Sudo
Journal:  J Pain Res       Date:  2021-05-18       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.